The consumer healthcare company Haleon has announced plans to establish its first manufacturing facility in India.
The firm said in a release that it would invest ₹2000 crore in a new state-of-the-art 40-acre greenfield site in Pithampur, Madhya Pradesh.
It added that the new manufacturing site will serve as a key enabler for Haleon's growth in India, strengthening supply chain resilience, driving domestic value addition and supporting exports across wider Asia.
The move is also aligned with the Indian government's 'Make in India' vision, with the investment expected to generate broad-based economic value during the next decade, enhancing export competitiveness, contributing to state revenues and integrating India further into global supply chains.
The facility is expected to generate up to 500 jobs, along with additional indirect employment opportunities.
Haleon added that there will be a strong emphasis on skill development, local talent and supplier ecosystems.
The firm will also aim to foster a diverse and inclusive workforce, with a target of up to 30% women employees at the site.
Shri Mohan Yadav, Chief Minister of Madhya Pradesh, said: "Madhya Pradesh continues to emerge as a preferred destination for global investment, driven by its robust infrastructure, skilled workforce and industry-friendly policies."
"Haleon's decision to establish its first manufacturing facility in India at Pithampur reflects the growing confidence of leading global companies in the state's growth potential and business ecosystem."
This ₹2000 crore investment will further strengthen Madhya Pradesh's position as a key manufacturing and export hub, while contributing to economic development and industrial advancement.
Brian McNamara, CEO, Haleon, added: "India is a key strategic market for Haleon and an important driver of our long-term growth."
This investment strengthens our local manufacturing footprint and expands our reach in one of the world's fastest-growing consumer health markets.
"By increasing access to our trusted brands and building our capabilities on the ground, we are well-positioned to capture the significant opportunities ahead."
"We aim to expand access to better everyday health for more than 300 million additional consumers in India. This will be key to achieving our broader ambition to reach one billion more consumers globally by 2030."
The facility is designed in accordance with Haleon's new global advanced blueprint and will feature cutting-edge automated manufacturing capabilities.
It is expected to become operational by 2029-2030, enabling Haleon to meet the increasing demand in both domestic and international markets.